Physician profile
Saba Barlas
NPI 1326731324
$3,510.78
in general payments reported to CMS, 2019-2025
18 companies · $2,499 in 2025
The $2,499 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,012 · 2025: $2,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,199 · Education: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,198.82 |
| Education | $311.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,031.90 | 2024-2025 | |
| Janssen Biotech, INC. | $417.14 | 2024-2025 | Tremfya, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $400.65 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $333.71 | 2024-2025 | Sotyktu |
| Ucb, INC. | $282.22 | 2024-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $244.64 | 2024-2025 | Nemluvio |
| Lilly USA, LLC | $182.44 | 2024-2025 | Ebglyss, Taltz |
| Organon LLC | $175.45 | 2025 | Vtama |
| Novartis Pharmaceuticals Corporation | $143.83 | 2024-2025 | |
| Organogenesis INC. | $72.38 | 2025 | Cygnus Dual, Novachor |
| Incyte Corporation | $52.95 | 2024-2025 | Opzelura |
| Genzyme Corporation | $32.34 | 2025 | |
| Botanix Sb INC | $32.33 | 2025 | Sofdra |
| Kerecis Limited | $32.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Reprise Biomedical, INC. | $21.95 | 2025 | Miro3d |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $19.86 | 2024 | Adbry |
| Journey Medical Corporation | $19.80 | 2025 | |
| Pfizer INC. | $15.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Barlas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.